July 27, 2021
Drug approval underscores the challenges of KRAS mutations in cancer
For all the advancements in targeted therapy, some targets remain elusive—among them, genes in the troublesome RAS family.
155 Posts
July 27, 2021
For all the advancements in targeted therapy, some targets remain elusive—among them, genes in the troublesome RAS family.
July 22, 2021
Doctors have identified a genetic feature—or biomarker—called homologous recombination deficiency that’s leading to positive outcomes for patients with ovarian cancer.
July 13, 2021
Telehealth may provide advantages for physicians and other health providers, especially when used in combination with in-office appointments.
July 6, 2021
When a patient walks through a door of a cancer center, he or she may follow any number of paths to get diagnosed and treated.
June 17, 2021
Disparities in cancer risk, incidences and deaths among Americans span many racial, ethnic and socio-economic lines.
June 15, 2021
Thinking of participating in a cancer clinical trial? This article explains how they work, who they're for, and the risks and benefits for patients.
June 3, 2021
Ovarian, fallopian tube and primary peritoneal cancers are the most common cause of death in women with cancer of the reproductive system
June 1, 2021
CAR T-cell therapy may transform some cancers from acute diseases with poor outcomes to chronic illnesses that may be managed with more positive results.
May 27, 2021
Oncologists have shown increasing interest in radiophamaceuticals—radioactive particles attached to drugs that are designed to precisely target and kill cancer cells.
Guidelines
The information contained in this blog is not intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition. Nothing contained in the blog is intended to be used for medical diagnosis or treatment of any illness, condition or disease.
Donate to Gateway for Cancer Research
Make a difference in the fight against cancer by donating to cancer research
Gateway for Cancer Research is a 501(c)(3) non-profit organization. Tax-ID: 73-1386920